Hasil Pencarian - Geraldine Ferron‐Brady

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    Clinical assessment of momelotinib drug–drug interactions via CYP3A metabolism and transporters

    Clinical assessment of momelotinib drug–drug interactions via CYP3A metabolism and transporters oleh Yu Liu Ho, Pete Gorycki, Geraldine Ferron‐Brady, Paul Martin, Georgios Vlasakakis

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Population pharmacokinetic modeling of molibresib and its active metabolites in patients with solid tumors: A semimechanistic autoinduction model

    Population pharmacokinetic modeling of molibresib and its active metabolites in patients with solid tumors: A semimechanistic autoinduction model oleh Anu Shilpa Krishnatry, Alexander Voelkner, Arindam Dhar, Marita Prohn, Geraldine Ferron‐Brady

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Exposure–response analysis of adverse events associated with molibresib and its active metabolites in patients with solid tumors

    Exposure–response analysis of adverse events associated with molibresib and its active metabolites in patients with solid tumors oleh Anu Shilpa Krishnatry, Eva Hanze, Tim Bergsma, Arindam Dhar, Marita Prohn, Geraldine Ferron‐Brady

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Population pharmacokinetics of belantamab mafodotin, a BCMA‐targeting agent in patients with relapsed/refractory multiple myeloma

    Population pharmacokinetics of belantamab mafodotin, a BCMA‐targeting agent in patients with relapsed/refractory multiple myeloma oleh Chetan Rathi, Jon Collins, Herbert Struemper, Joanna Opalinska, Roxanne C. Jewell, Geraldine Ferron‐Brady

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Building an adaptive dose simulation framework to aid dose and schedule selection

    Building an adaptive dose simulation framework to aid dose and schedule selection oleh Richard Hooijmaijers, Ridhi Parasrampuria, Eleonora Marostica, Geraldine Ferron‐Brady, Teun M. Post, Sandra A. G. Visser

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Longitudinal efficacy and safety modeling and simulation framework to aid dose selection of belantamab mafodotin for patients with multiple myeloma

    Longitudinal efficacy and safety modeling and simulation framework to aid dose selection of belantamab mafodotin for patients with multiple myeloma oleh Jon Collins, Martijn vanNoort, Chetan Rathi, Teun M. Post, Herbert Struemper, Roxanne C. Jewell, Geraldine Ferron‐Brady

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Momelotinib: Mechanism of action, clinical, and translational science

    Momelotinib: Mechanism of action, clinical, and translational science oleh Georgios Vlasakakis, Michael T. McCabe, Yu Liu Ho, Geraldine Ferron‐Brady, Paul Martin, Darren Bentley, Catherine Ellis, Mary Antonysamy, Sandra A. G. Visser

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor

    Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor oleh Samit R. Joshi, Disala Fernando, Stephanie Igwe, Litza McKenzie, Anu S. Krishnatry, Fiona Halliday, Joyce Zhan, Thomas J. Greene, Jianfeng Xu, Geraldine Ferron‐Brady, Max Lataillade, Sherene Min

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-trans retinoic acid in acute myeloid leukemia across subtypes

    Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-trans retinoic acid in acute myeloid leukemia across subt... oleh Kimberly N. Smitheman, Tesa M. Severson, Satyajit R. Rajapurkar, Michael T. McCabe, Natalie Karpinich, James Foley, Melissa B. Pappalardi, Ashley Hughes, Wendy Halsey, Elizabeth Thomas, Christopher Traini, Kelly E. Federowicz, Jenny Laraio, Fredrick Mobegi, Geraldine Ferron-Brady, Rabinder K. Prinjha, Christopher L. Carpenter, Ryan G. Kruger, Lodewyk Wessels, Helai P. Mohammad

    Diterbitkan 2019-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: